Evidence map›Paper›PMID 27814404›Full record

ArticlePloS one2016

Enterovirus D-68 Infection, Prophylaxis, and Vaccination in a Novel Permissive Animal Model, the Cotton Rat (Sigmodon hispidus).

Mira C Patel, Wei Wang, Lioubov M Pletneva, Seesandra V Rajagopala, Yi Tan, Tina V Hartert, Marina S Boukhvalova, Stefanie N Vogel, Suman R Das, Jorge C G Blanco

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Mira C PatelSigmovir Biosystems Inc., Rockville, Maryland, United States of America.
Wei WangInfectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, United States of America.
Lioubov M PletnevaSigmovir Biosystems Inc., Rockville, Maryland, United States of America.
Seesandra V RajagopalaInfectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, United States of America.
Yi TanInfectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, United States of America.
Tina V HartertDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Marina S BoukhvalovaSigmovir Biosystems Inc., Rockville, Maryland, United States of America.
Stefanie N VogelDepartment of Microbiology and Immunology, University of Maryland, Baltimore, Maryland, United States of America.
Suman R DasInfectious Diseases Group, J. Craig Venter Institute, Rockville, Maryland, United States of America.ORCID http://orcid.org/0000-0003-2496-9724
Jorge C G BlancoSigmovir Biosystems Inc., Rockville, Maryland, United States of America.ORCID http://orcid.org/0000-0002-6173-0213
J. Craig Venter Institute · USSigmovir Biosystems (United States) · USUniversity of Maryland, Baltimore · USVanderbilt University Medical Center · US

Funding

The J. Craig Venter Institute Genome Center for Infectious DiseasesU19AI110819 · NIAID · J. CRAIG VENTER INSTITUTE, INC. · PI TAN, GENE · 2014 to 2018
$29.7M
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenzaR01AI104541 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BLANCO, JORGE C, VOGEL, STEFANIE N. · 2013 to 2016
$3.4M
Midcareer Investigator Patient-oriented Research Award in Bronchiolitis & AsthmaK24AI077930 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARTERT, TINA V · 2008 to 2017
$1.6M
NIAID NIH HHS K24 AI077930NIAID NIH HHS R01 AI104541NIAID NIH HHS U19 AI110819
6 · The paper itself

Abstract

In recent years, there has been a significant increase in detection of Enterovirus D-68 (EV-D68) among patients with severe respiratory infections worldwide. EV-D68 is now recognized as a re-emerging pathogen; however, due to lack of a permissive animal model for EV-D68, a comprehensive understanding of the pathogenesis and immune response against EV-D68 has been hampered. Recently, it was shown that EV-D68 has a strong affinity for α2,6-linked sialic acids (SAs) and we have shown previously that α2,6-linked SAs are abundantly present in the respiratory tract of cotton rats (Sigmodon hispidus). Thus, we hypothesized that cotton rats could be a potential model for EV-D68 infection. Here, we evaluated the ability of two recently isolated EV-D68 strains (VANBT/1 and MO/14/49), along with the historical prototype Fermon strain (ATCC), to infect cotton rats. We found that cotton rats are permissive to EV-D68 infection without virus adaptation. The different strains of EV-D68 showed variable infection profiles and the ability to produce neutralizing antibody (NA) upon intranasal infection or intramuscular immunization. Infection with the VANBT/1 resulted in significant induction of pulmonary cytokine gene expression and lung pathology. Intramuscular immunization with live VANBT/1 or MO/14/49 induced strong homologous antibody responses, but a moderate heterologous NA response. We showed that passive prophylactic administration of serum with high content of NA against VANBT/1 resulted in an efficient antiviral therapy. VANBT/1-immunized animals showed complete protection from VANBT/1 challenge, but induced strong pulmonary Th1 and Th2 cytokine responses and enhanced lung pathology, indicating the generation of exacerbated immune response by immunization. In conclusion, our data illustrate that the cotton rat is a powerful animal model that provides an experimental platform to investigate pathogenesis, immune response, anti-viral therapies and vaccines against EV-D68 infection.

Indexed as

AnimalsAntibodies, NeutralizingAntibodies, ViralDisease Models, AnimalEnterovirusEnterovirus InfectionsFemaleLungRatsRespiratory Tract InfectionsSigmodontinaeVaccinationAntibodies, NeutralizingAntibodies, Viral

Identifiers

PMID27814404
PMCPMC5096705
OpenAlexW2548597549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.